Co-Diagnostics Inc $ 13.99 0.1 (0.72%)
Volume:
934,057
Avg Vol (1m):
1,778,820
Market Cap $:
394.37 Mil
Enterprise Value $:
367.09 Mil
PE Ratio:
15.51
PB Ratio:
7.83
Current and historical daily P/E ratio for CODX (Co-Diagnostics Inc) from 2017 to Mar 02 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Co-Diagnostics stock (CODX) PE ratio as of Mar 02 2021 is 15.51.
More Details
Co-Diagnostics PE Ratio (TTM) Chart
EMBED
Co-Diagnostics PE Ratio (TTM) Historical Data
View and export this data going back to 2017. Start your Free Trial
Total 915
- 1
- 2
- 3
- 4
- 5
- 6
- 11
Co-Diagnostics PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2021-03-02 | 15.5 | 2020-12-24 | 12.0 |
2021-03-01 | 15.4 | 2020-12-23 | 12.1 |
2021-02-26 | 15.3 | 2020-12-22 | 12.5 |
2021-02-25 | 17.1 | 2020-12-21 | 12.7 |
2021-02-24 | 18.5 | 2020-12-18 | 12.3 |
2021-02-23 | 16.7 | 2020-12-17 | 12.1 |
2021-02-22 | 17.6 | 2020-12-16 | 11.9 |
2021-02-19 | 18.9 | 2020-12-15 | 12.2 |
2021-02-18 | 17.7 | 2020-12-14 | 11.8 |
2021-02-17 | 19.1 | 2020-12-11 | 11.3 |
2021-02-16 | 20.2 | 2020-12-10 | 11.6 |
2021-02-15 | 18.9 | 2020-12-09 | 11.3 |
2021-02-12 | 18.9 | 2020-12-08 | 11.5 |
2021-02-11 | 18.0 | 2020-12-07 | 11.8 |
2021-02-10 | 19.9 | 2020-12-04 | 12.3 |
2021-02-09 | 21.3 | 2020-12-03 | 12.0 |
2021-02-08 | 18.8 | 2020-12-02 | 12.2 |
2021-02-05 | 17.2 | 2020-12-01 | 12.3 |
2021-02-04 | 17.4 | 2020-11-30 | 13.0 |
2021-02-03 | 16.3 | 2020-11-27 | 13.2 |
2021-02-02 | 15.4 | 2020-11-25 | 13.5 |
2021-02-01 | 15.8 | 2020-11-24 | 11.7 |
2021-01-29 | 14.3 | 2020-11-23 | 11.7 |
2021-01-28 | 14.0 | 2020-11-20 | 12.3 |
2021-01-27 | 14.6 | 2020-11-19 | 12.1 |
2021-01-26 | 13.9 | 2020-11-18 | 12.7 |
2021-01-25 | 13.4 | 2020-11-17 | 13.2 |
2021-01-22 | 13.1 | 2020-11-16 | 15.1 |
2021-01-21 | 13.2 | 2020-11-13 | 16.6 |
2021-01-20 | 13.2 | 2020-11-12 | 16.9 |
2021-01-19 | 13.1 | 2020-11-11 | 14.8 |
2021-01-15 | 11.7 | 2020-11-10 | 13.1 |
2021-01-14 | 11.3 | 2020-11-09 | 12.8 |
2021-01-13 | 11.2 | 2020-11-06 | 16.0 |
2021-01-12 | 11.5 | 2020-11-05 | 16.1 |
2021-01-11 | 11.6 | 2020-11-04 | 15.8 |
2021-01-08 | 12.2 | 2020-11-03 | 15.6 |
2021-01-07 | 12.0 | 2020-11-02 | 14.7 |
2021-01-06 | 11.7 | 2020-10-30 | 14.9 |
2021-01-05 | 11.5 | 2020-10-29 | 15.3 |
2021-01-04 | 11.1 | 2020-10-28 | 15.1 |
2020-12-31 | 10.3 | 2020-10-27 | 15.8 |
2020-12-30 | 10.8 | 2020-10-26 | 15.6 |
2020-12-29 | 10.9 | 2020-10-23 | 13.8 |
2020-12-28 | 11.2 | 2020-10-22 | 13.5 |
Co-Diagnostics PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Compare
NAS:LNTH
NAS:SRDX
NAS:AXDX
OTCPK:GWHP
NAS:PACB
NAS:VIVO
NAS:PSNL
NAS:QTNT
NAS:CSTL
NAS:FLGT
NYSE:TMO
NYSE:DHR
NAS:ILMN
XAMS:PHIA
XSWX:LONN
NAS:DXCM
NYSE:IQV
NYSE:A
NAS:IDXX
SHSE:603259
Address
2401 South Foothill Drive, Salt Lake City, UT, USA, 84109
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV. The company's diagnostics systems enable very rapid, low-cost, sophisticated molecular testing for organisms and genetic diseases by greatly automating historically complex procedures in both the development and administration of tests.